The cure rate for [diffuse midline glioma] is less than 1%, and the median overall survival is nine to 11 months,” said Dr.

That was on Nov. 25. This time, Chen, as part of a clinical trial at Rhode Island Hospital used a radiation treatment, on the ...

A schoolboy died from a deadly brain tumor after his weight doubled in 16 months. Luke Poga’s mum Sam, 42, initially attributed the nine-year-old’s rapid weight gain to a lack of exercise during the ...

A study led by Dr. Peter Canoll's lab, in collaboration with researchers at Columbia University Irving Medical Center, ...

A type of aggressive, treatment-resistant brain tumor has a distinct population of immune cells that support its growth, according to new research.

A type of aggressive, treatment-resistant brain tumor has a distinct population of immune cells that support its growth, ...

Stephen Blakeston, 53 when he died, began experiencing troubling symptoms in October 2010, including jumbled speech, severe ...

CHICAGO, IL / ACCESS Newswire / February 10, 2025 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in ...

A groundbreaking immunotherapy is showing unprecedented success against one of the deadliest childhood brain cancers — ...

This study presents a new prognostic model using mitophagy-related genes (MRGs) in glioma, a type of brain tumor, developed through bioinformatics. The model seeks to improve the understanding of ...

Treatment with Tafinlar in combination with Mekinist showed what researchers described as “considerable efficacy” among ...

The California Institute for Regenerative Medicine has awarded a $6 million grant to USC investigators pioneering a new first ...